HI homepage

interventional radiology philips
Interventional radiologists who neglect E&M visits risk losing more lucrative procedures

“This study affirms that when interventional radiologists are afforded the time to evaluate and follow their patients, the complexity and value of the care they provide increases," one expert notes. 

merger acquisition handshake deal business agreement partnership
RadNet expands partnership with GE HealthCare, acquires another tech company

GE plans to integrate DeepHealth AI solutions into its ultrasound portfolio, with RadNet also recently acquiring cloud services provider Cimar UK. 

Siemens Healthineers
Siemens to unload majority stake in Healthineers imaging business

The Munich, Germany-based company is doing so by transferring 30% of total shares in Siemens Healthineers over to the parent company’s stockholders. 

quality
American College of Radiology updates imaging appropriateness criteria with 13 new topics

Its latest update covers scenarios such as abdominal or chest pain in a pediatric patient, chronic pancreatis, and imaging after a liver transplant. 

Thumbnail
Less than 30% of FDA-authorized radiology AI devices have undergone clinical testing

A new research paper details the path to approval for nearly 1,000 AI/ML algorithms, highlighting significant gaps in testing.

warning safety alert recall healthcare issue
Hospital alerts dozens after failure to relay imaging results turns deadly

Health officials launched a review of over 21,000 imaging exams after determining that numerous patients had pertinent findings fly under the radar for months. 

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.